cannabis & hemp regulation news on the topic of:

Lab Testing & QA

WADA THC Threshold 2026: What Athletes, CBD Brands & Sports Organizations Need to Know

The World Anti-Doping Agency's in-competition THC threshold remains 150 ng/mL urinary in 2026, shaping rules for athletes, CBD brands, and sports organizations.

Guide

Hemp Compliance Software 2025: What Cannabis Brands Actually Need (AI-Powered Guide)

What hemp compliance software should track in 2025: state-law changes, COA validation, label rules, multi-state ops, and where AI replaces manual work.

Analysis

Cannabis Lab Testing Standards Tighten in 2026: Potency Audits, Lab Shopping Crackdowns, and ISO 17025

Cannabis lab testing standards in 2026 are tightening through potency audits, lab shopping crackdowns, and broader ISO 17025 accreditation expectations.

Template / SOP

Distributor Agreements for THC Beverages: Indemnity and Recall Cost-Sharing Templates

THC beverage distributor agreements need defined indemnity events, recall cost allocation, and communication control to manage product holds and withdrawals.

Guide

Cannabis Product Recall Insurance: What Underwriters Require in 2026 Applications

Cannabis recall insurance underwriters in 2026 require documented product risk profiles, supplier controls, traceability evidence, and response readiness.

Analysis

Hemp 'Chemical Conversion' in 2026: The Evidence Standard for Proving 'Naturally Derived' vs. 'Synthetic' Cannabinoids

Why 2026 enforcement treats many hemp products as synthetic or artificially derived, and what evidence proves cannabinoids are naturally derived from hemp.

Analysis

Federal Spotlight 2025: GAO’s Food‑Contact Substance Critique—Packaging Risk for THC/CBD Beverages

A GAO report urging FDA to strengthen its Food Contact Substances program raises packaging migration and audit risk for THC and CBD beverage brands.

Analysis

Alberta 2025: Inside AGLC’s THC Potency Audit—Common Failures and How to Fix Them

Alberta AGLC 2025 secondary testing program shows potency variance and labeling issues drive most compliance breakdowns rather than contamination findings.

Analysis

Ontario 2025: OCS THC Potency Testing Pilot Results—Label Accuracy and Supplier Audits

Ontario's 2025 OCS THC potency testing pilot exposes label inflation in high-THC SKUs and reshapes supplier audits across the regulated adult-use catalog.

Guide

Lead‑Free by Design: 2025 Procurement Specs for Vape Hardware That Survive Prop 65 and Retailer Audits (California)

California Proposition 65 exposure on vape hardware in 2025 demands a procurement-led lead-free program with wetted-part controls and lot-level verification.

Guide

Wildfire Smoke Taint and 2025 Harvests: Testing, Labeling, and Recall Triage for Outdoor Cannabis and Hemp in Oregon

Oregon outdoor cannabis and hemp operators face 2025 wildfire smoke taint risks; practical guide to testing, labeling, and recall triage before packaging.

Guide

EU Batteries Regulation (EU) 2023/1542 for Vape Devices: EPR, Labeling, and Battery Passports on the Horizon

EU Regulation 2023/1542 brings producer responsibility, labeling, and forthcoming battery passport duties to vape device brands selling into Member States.

Guide

California’s New Indoor Heat Rule Hits Cannabis Facilities: Warehouse, Grow, and Beverage Plant Requirements Before Winter 2025

Cal/OSHA 8 CCR 3396 Indoor Heat Illness Prevention rule has applied since July 23, 2024, covering cannabis cultivation, extraction, and beverage facilities.

Guide

New England’s THC Beverage Triangle: Cross‑Border Ship‑Block Rules for MA, NH, and ME in 2025–2026

Massachusetts, New Hampshire, and Maine handle intoxicating hemp and low-dose THC drinks under different 2025-2026 frameworks, forcing ship-block routing rules.

Guide

GFSI or Bust: Why THC‑Beverage Co‑Packers Need SQF/BRCGS in 2025

In 2025, retailers and marketplaces require GFSI-benchmarked SQF or BRCGS certification before stocking hemp-derived THC beverages from co-packers.

Guide

EPA’s September 2025 Aquatic Benchmarks Meet Cannabis: Emulsifiers, Pesticides, and Wastewater Permit Risks

EPA's September 2025 Aquatic Life Benchmarks update indirectly raises wastewater, pretreatment, and pesticide risk for cannabis and hemp processing.

News

Canada 2025: No More 60‑Day Notices for New Dried/Fresh Cannabis—What It Means for CBD Flower and THCa

Health Canada removed the 60-day Notice of New Cannabis Product for dried and fresh cannabis in 2025, speeding flower launches without easing testing.

Guide

Metals and Can‑Liner Migration in THC/CBD Beverages: 2025 Testing Plans to Prevent Recalls

Aluminum can liner migration and emulsion drift are emerging recall drivers for THC beverages in 2025, with California posting packaging-tied recalls.

Guide

Co‑Manufacturing Hemp and Cannabis Under One Roof: Licenses, Segregation, and GMP to Prevent Cross‑Contamination (2025–2026 Compliance Guide)

Co-manufacturing hemp and state-regulated cannabis under one roof in 2025 demands documented segregation, GMP controls, and verifiable diversion safeguards.

News

Pennsylvania 2025: The New Hemp Guild’s Policy Wishlist—Age‑21 Rules, Potency Caps, and Testing

A new Pennsylvania hemp trade group launched late 2025 is pushing age-21 access, potency caps, and a clear line between CBD wellness and delta-8 products.

Guide

BPA and PFAS in Can Liners: A 2025 Vendor Spec and Testing Plan for THC Drinks

THC beverage brands in 2025 face BPA-NI and PFAS-free can liner attestations, driven by EPA PFAS rules, state packaging bans, and retailer vendor specs.

Guide

UL 8139 + IEC 62133 + UN38.3: The 2025 Safety Spec Retailers Should Demand for THC Vapes

UL 8139, IEC 62133-2, and UN 38.3 form the 2025 procurement spec retailers should demand from THC vape suppliers to survive carrier and hazmat rules.

Guide

FSMA 204 + Metrc: A Dual‑Traceability Playbook for Hemp‑THC Beverages in 2025

Hemp-THC beverage operators must align FDA FSMA 204 Food Traceability Rule records with state Metrc track-and-trace before the January 20, 2026 deadline.

Guide

Kosher and Halal for Cannabinoid Beverages: What’s Certifiable, What Isn’t, and How Audits Work in 2025

Kosher and halal certification for cannabinoid beverages in 2025 hinges on ingredient acceptability, audit readiness, and change-control at scaling co-packers.

Guide

Nanoemulsions Under FSMA: Hazard Analyses, Challenge Studies, and Shelf‑Life Plans That Survive 2025 Audits

Nanoemulsified cannabinoid beverages face heightened 2025 FSMA scrutiny under 21 CFR Part 117, requiring updated hazard analyses and shelf-life challenge plans.

Guide

Co‑Packer Contracts for THC Beverages: Recall Authority, Insurance, and IP Ownership in 2025–2026

THC beverage co-packer contracts in 2025 must allocate recall authority, insurance limits, and intellectual property ownership to survive retailer QA audits.

Analysis

FY2026 Ag‑FDA Appropriations Watch: A Federal Potency‑Limit Directive for Hemp? What FDA/HHS Rulemaking Could Look Like

An FY2026 Agriculture-FDA appropriations directive on intoxicating hemp could become the first durable federal framework for finished-product potency limits.

Analysis

Colombia 2025: New Foreign Trade Rules and Pharmacy Flower — An EU‑GMP Export Roadmap

Colombia's 2025 VUCE foreign trade updates and Decree 1138 of 2025 reshape medical cannabis exports and authorize pharmacy flower under EU-GMP prescription.

News

California 2025: DCC’s Pesticide Action Level Overhaul — New COA Thresholds, Lab Methods, and Recall Risk

California DCC mid-2025 rulemaking overhauls cannabis pesticide action levels with DPR health-based input, raising COA, method, and recall transition risk.

Analysis

FDA’s 2025 Food Colors Agenda Meets THC Drinks: Natural Color Additives, Labeling, and GRAS Traps

FDA's 2025 Human Foods Program signaled new natural color additive guidance, exposing THC beverages to color additive premarket review and misbranding risk.

News

USP <1568> Is Back: Quality Considerations for Cannabis Research Products in 2025–2026

USP republished draft General Chapter 1568 and the proposed CBD monograph in Pharmacopeial Forum 51(3) for September to October 2025 cannabis research review.

Analysis

Norway 2025: Zero‑THC or Nothing—Importing CBD Without Novel Food or Trace THC

Norway's 2025 CBD import posture demands zero detectable THC, with seizures through September 2025 and Novel Food or medicines hurdles for ingestibles.

Guide

US EPA's Rules Are Converging on Cannabis Facilities: A 2025–2027 Environmental Compliance Checklist

U.S. EPA programs covering TSCA, Clean Air Act RMP, PFAS, and wastewater pretreatment are stacking on cannabis manufacturing and extraction sites through 2027.

Guide

Voluntary Cannabinoid Labeling Standards Are Here: How to Use ASTM D37 to Reduce Retail Risk in 2025

ASTM D37 voluntary cannabinoid labeling standards give U.S. retailers a defensible framework to reduce label-driven enforcement and litigation risk.

Guide

When Do Hemp Edibles Need LAAF‑Accredited Lab Testing? A 2025 Import and Enforcement Guide

FDA's LAAF accreditation is mandatory for specific import-related hemp edibles testing in 2025, with ISO/IEC 17025 covering most routine quality work.

Guide

Methylene Chloride Restrictions Are Here: What Cannabis Labs and Extractors Must Change by 2025–2027

EPA's 2024 TSCA rule on methylene chloride pushes cannabis labs and extractors into a Workplace Chemical Protection Program with 2025-2027 milestones.

Guide

Pesticide Residues in Food‑Grade Hemp: EPA Tolerances, State Cannabis Lists, and FSMA Supply‑Chain Controls in 2025

Food-grade hemp ingredients must meet EPA pesticide tolerances under FFDCA while reconciling state cannabis residue lists and FSMA supply-chain rules.

Guide

Hemp Seed Truth‑in‑Labeling: 2025 AOSCA Certification, Varietal Claims, and Interstate Seed Sale Pitfalls

Interstate hemp seed sales in 2025 hinge on AOSCA certification, varietal truth-in-labeling, and total-THC compliance under post-decarboxylation testing.

News

After DOJ Cancels Pending Cannabis Rules: What It Means for Hemp Testing, Research, and 2025–2026 Timelines

DOJ's September 2025 Federal Register notice withdrew DEA rulemakings on analytical labs and hemp (RIN 1117-AB77) and cannabis research (RIN 1117-AB83).

Analysis

Panama's Seven Licensees: GMP, Labeling, and Import/Export Rules Before First Medical Cannabis Sales

Panama's MINSA confirmed seven Ley 242 medical cannabis licenses, shifting compliance focus to GMP readiness, product authorization, and import-export work.

Analysis

Ghana 2025: 0.3% THC Guidelines Headed to Parliament—Licensing, Testing, and Labeling Under the New Regime

Ghana's government will lay 0.3% THC cultivation guidelines before Parliament in late 2025, anchored to the Narcotics Control Commission Act framework.

News

Morocco’s Breakout Year: First Legal Exports and 67 Approved Cannabis Products—ANRAC Compliance for 2025–2026

Morocco logged its first legal cannabis exports in 2025 with 67 ANRAC-approved products under Law 13-21, opening medical and industrial supply channels.

Analysis

After the D.C. Circuit Pauses Parts of EPA’s PFAS Rule: What THC and CBD Beverage Plants Must Change Now

EPA's September 2025 request to the D.C. Circuit to vacate parts of its PFAS drinking water rule reshapes water testing duties for THC and CBD beverage plants.

Guide

Hemp‑THC M&A in 2025: The Compliance Due‑Diligence Checklist Buyers Demand (and Sellers Should Prepare)

Hemp-THC M&A buyers in 2025 underwrite regulatory survivability, discounting SKUs at risk under state caps, 4th and 8th Circuit rulings, and FTC exposure.

Guide

COA Fraud Is Spiking in 2025: Digital Signatures, Raw Data Links, and Retailer Audit Playbooks That Actually Work

COA fraud in 2025 ranges from edited PDFs to mismatched lot IDs and Franken-COAs, pushing retailers toward digital signatures, raw data links, and audits.

Guide

2D Barcode Sunrise 2027 Comes Fast: POS and Recall‑Ready Labels for Hemp‑THC Beverages You Must Build in 2025

GS1 US 2D Barcode Sunrise 2027 expects retailers to scan QR or DataMatrix at POS, requiring hemp-THC beverage brands to plan GS1 Digital Link migration in 2025.

Guide

California's "No Detectable THC" Standard Meets the Lab: LOQ vs. LOD, Method Selection, and Appeal Paths

California's DPH-24-005 makes no-detectable THC the permanent hemp baseline, putting lab method choice, LOQ versus LOD, and COA appeals center stage.

Analysis

Morocco 2025: First Legal Cannabis Exports and 67 Approved Products—EU‑GMP and Export Docs Explained

Morocco shipped its first legal medical cannabis export in 2025 and approved 67 products, raising the bar on EU-GMP standards and export documentation.

Guide

UK 2025: FSA's CBD Reformulation and ADI Labeling Guidance—A Retail Compliance Checklist

The UK Food Standards Agency's 2025 CBD guidance pushes Public List brands to reformulate to current ADI levels and adopt new mandatory label disclosures.

Analysis

EFSA's September 2025 CBD Safety Update: What It Signals for EU Novel Food Authorizations in 2026

EFSA's September 8, 2025 CBD safety update raises the dose-response and impurity bar for EU Novel Food applications heading into 2026 authorizations.

Guide

Retailer–Lab Contracts After 2025 Recalls: Indemnities, Access to Raw Data, and Who Owns the COA

After 2025's wave of cannabis lab suspensions and COA retractions, retailer-lab contracts need new indemnity, raw data access, and COA ownership terms.

Guide

COA QR Codes 2.0: Using GS1 Digital Link to Survive 2025 QR Recall Checks and Marketplace Audits

Cannabis COA QR codes in 2025 must move beyond static PDF links toward GS1 Digital Link to survive batch-level recall checks and retailer marketplace audits.

Guide

Shelf‑Life Proof for Nano THC Drinks: 2025 Testing Plans That Satisfy Auditors and Retail Chains

Nano THC beverage brands in 2025 must back labeled milligram strength with full shelf-life stability data to satisfy state auditors and major retail chains.

Guide

PFAS and RCRA Are Coming for THC Drinks: Managing Filters, Washwater, and Packaging Waste in 2025–2026

EPA 2024 PFAS drinking water standards and expanded RCRA waste rules force 2025-2026 filter, washwater, and packaging controls on THC beverage manufacturers.

Guide

Wastewater and THC Drinks: Pretreatment, Surfactants, and Local Limits for Beverage Plants

THC and CBD beverage plants face 40 CFR Part 403 pretreatment scrutiny in 2025, with POTWs setting local limits for surfactants and cannabinoid residuals.

Analysis

Labs Under the Microscope in 2025: Recalls, Suspensions, and How Retailers Should Vet COAs Before Stocking

New York, California, and Oklahoma cannabis lab suspensions in 2025 are driving retailer recalls, making rigorous Certificate of Analysis vetting essential.

Analysis

After JECFA 100: Why Global Food Standards Still Don't Resolve the CBD Gray Area in 2025

After JECFA's 100th session, global food standards still leave CBD in a 2025 regulatory gray area, with no Codex maximum levels or harmonized path.

Analysis

ASTM D37's New Vape Ingredient Safety Standard: Terpenes, Flavorants, and Retailer Liability in 2025

ASTM D37's new vape ingredient safety standard sets rules for terpenes and flavorants, raising retailer liability for non-conforming cannabis vapes.

Analysis

USP’s Draft CBD Monograph Reopened in 2025: What May Change in Specs, Impurities, and Testing Methods

USP reopened its draft CBD monograph in 2025 with public comment closing July 31, 2025, signaling new specs, impurity limits, and testing method shifts.

Analysis

FDA Human Foods Program 2025: Reading the Guidance Agenda for CBD in Foods and Supplements

The FDA Human Foods Program 2025 guidance agenda signals tighter post-market scrutiny on CBD, CBN, and CBG and expanded adverse event reporting integration.

Guide

FDA’s BVO Ban and THC Beverages: Reformulation Deadlines, Emulsifier Alternatives, and Label Fixes

The FDA brominated vegetable oil ban forces THC and hemp beverage brands to reformulate emulsions, update labels, and document supply chain attestations.

News

North Dakota 2025: Medical Cannabis Edibles Arrive—Packaging, Labeling, and Dosing Readiness

North Dakota's 2025 medical cannabis edibles rollout introduces packaging, labeling, and dosing requirements that dispensaries and processors must meet.

News

Texas Q4 2025: DSHS-Led Hemp Cannabinoid Rules on Deck—Testing, Labels, Fees, and Multi-Agency Enforcement

Texas DSHS will issue Q4 2025 hemp cannabinoid rules on testing, labeling, fees, and multi-agency oversight that retailers must prepare for now.

Analysis

New Testing Baselines in 2025: NIST’s Hemp Reference Material and AOAC CASP Methods Raise the Bar

NIST's 2025 hemp reference material and AOAC's CASP program give cannabis and hemp labs a federal scientific baseline for total THC, CBD, and metals testing.

News

Kansas 2025: SB 292 Targets Intoxicating Hemp—Age‑21 Sales, Potency Caps, and Testing On Deck?

Kansas SB 292 targets intoxicating hemp in 2025 with age-21 sales, potency caps, and mandatory testing, reshaping retail and manufacturer duties.

Analysis

Sweden 2025: Zero‑THC or Bust—Selling CBD Without Novel Food or Edibles

Sweden's 2025 stance enforces a zero-THC threshold for CBD and refuses novel food and edibles channels, narrowing legal sales paths for hemp brands.

Analysis

EPA’s 2025 PFAS Drinking Water Changes: What THC and CBD Beverage Manufacturers Must Fix

EPA's May 2025 PFAS drinking water revisions extend deadlines but keep 4 ppt limits, pressuring THC and CBD beverage producers to audit water and supply chains.

Guide

DOT Oral-Fluid Testing Goes Live: Delta‑9 Cutoffs, Lab Certification, and Employer Playbooks for Late 2025

HHS's September 2, 2025 oral fluid testing update measures delta-9 THC directly, finalizing DOT collection protocols for federal safety-sensitive employers.

Analysis

Schedule III, Then What? Rescheduling’s Hidden Compliance Ripple Effects in 2025–2026

Federal cannabis rescheduling to Schedule III would end IRC 280E and open research pathways, but state licensing and many federal controls stay in place.

Analysis

EU 2025: EFSA’s Tougher Novel Food Dossier Rules Put CBD Back to Square One

EFSA's 2025 Novel Food guidance demands deeper human safety and toxicology data for CBD dossiers, keeping all CBD extracts unauthorized across the EU market.

Guide

South Dakota 2025: From HB 1125 to Summer Seizures—How to Audit Hemp Inventory for Compliance

South Dakota HB 1125 bans chemically modified hemp cannabinoids including delta-8 and delta-10, with 2025 seizures forcing retail inventory audits.

News

New Mexico’s 2025 Emergency Hemp Rule: Synthetic THC Bans, Testing Gaps, and What Retailers Must Change by Q4

New Mexico's Environment Department emergency rule effective September 1, 2025 bans synthetic and chemically converted hemp cannabinoids like delta-8.

Guide

Netherlands 2025: Coffee Shops Enter Fully Regulated Supply—A Compliance Playbook for the Cannabis Experiment

From April 7, 2025, coffee shops in the Dutch Wietexperiment's 10 municipalities must source cannabis only from accredited, government-approved cultivators.

Guide

Hawaii 2025: DOH Interim Hemp Rules, 1 mg THC Servings, and a Registration Path for Retail Sales

Hawaii's Department of Health interim rules cap edible hemp at 1 mg THC per serving and 5 mg per package, with mandatory testing and child-resistant packaging.

Guide

Iowa 2025: HF 2605 Goes Live—4 mg Servings, 10 mg Packages, and HHS Enforcement Guidance

Iowa HF 2605 caps consumable hemp at 4 mg total THC per serving and 10 mg per package, with HHS enforcement targeting synthetic cannabinoids in 2025.

Analysis

Oklahoma 2025: The Delta‑8 Loophole Lives—for Now. Governor Pressure, OMMA Limits, and What Retailers Should Expect

Oklahoma's hemp-derived delta-8 market remains legal in late 2025 outside OMMA jurisdiction, but Governor Stitt is pressing for coordinated enforcement.

Analysis

New Hampshire 2025: Total‑THC Crackdown Emerges in Bills as Lawmakers Debate Adult‑Use

New Hampshire HB 75 would legalize adult-use cannabis for ages 21 and over in 2025 while companion bills target total-THC in hemp-derived intoxicants.

Analysis

North Carolina’s New Chapter 18D: 2025 Legislative Push to Regulate Hemp‑Derived Consumables Before a 2026 Go‑Live

North Carolina HB 328, SB 265, and HB 607 would establish Chapter 18D for hemp-derived consumables with age limits and licensing, targeting July 1, 2026.

Analysis

Japan’s Shift to Ingredient-Based Rules: New THC Residue Standards and What They Mean for Hemp CBD

Japan's 2025 Cannabis Control Act reform moves from plant-part rules to ingredient-based THC residue standards, reshaping compliance for hemp CBD products.

Analysis

UK's First CBD Food Authorizations? Inside FSA's 2025 Consultation and the Road Beyond the Public List

The UK Food Standards Agency's August 2025 consultation could deliver Britain's first full CBD novel food authorizations — ending the interim public-list era.

News

USDA's DEA-Lab Testing Delay Through Dec. 31, 2025: Harvest Planning and State Plan Pitfalls

USDA extended its DEA-registered lab testing deadline for hemp through December 31, 2025 — what growers and state plan administrators should do next.

News

FDA Adds Hemp Cannabinoids to Adverse Event Reporting: What Compliance Teams Must Do Now

FDA's June 2025 proposal under Docket FDA-2024-N-5468 adds hemp cannabinoids to adverse-event reporting, raising new surveillance risk for CBD and CBG brands.

News

Louisiana 2025 Emergency Hemp Rules: 5 mg Servings, 12‑oz Minimums, and Retail Crackdown

Louisiana Department of Health emergency rules, effective May 2, 2025, cap hemp at 5 mg THC per serving and require a 12-fluid-ounce minimum for beverages.

Guide

Oregon’s 2025 CBN Clampdown: GRAS/NDIN or Goodbye for Artificially Derived Cannabinoids

Oregon OLCC bulletin CE2025-05 requires artificially derived CBN products to meet federal GRAS or NDIN standards by July 1, 2025, or leave shelves.

Analysis

New York 2025: Will Albany Codify a 15:1 CBD:THC Rule for Cannabinoid Hemp?

New York OCM is weighing a 15 to 1 CBD-to-THC ratio rule for cannabinoid hemp products in 2025 alongside its existing ban on delta-8 and delta-10 isomers.

News

Ohio’s 2025 Hemp Rewrite: Dispensary-Only Sales and Potency Caps Move Through the Statehouse

Ohio's 2025 intoxicating hemp bill would push delta-8 and similar cannabinoids into dispensary-only sales with potency caps as it moves through the Statehouse.

Guide

Colorado's 2025 Playbook for Intoxicating Hemp: Ratios, mg Caps, and Safe Harbor Compliance

Colorado's 6 CCR 1010-24 sets one of the toughest hemp regimes nationally: cannabinoid mg caps, CBD:THC ratios, and a safe harbor framework for 2025.

Analysis

Risk & Reward: The Emerging Business Landscape After 2025's Proposed Hemp Law Overhauls

How 2025's proposed federal and state hemp law overhauls reshape licensing, consumer protections, and competitive positioning for hemp operators nationwide.

Analysis

Next-Gen Regulation: Will Synthetic and Semi-Synthetic Cannabinoids Survive 2025?

FDA and DEA scrutiny in 2025 puts synthetic and semi-synthetic hemp-derived cannabinoids on uncertain footing, with enforcement actions reshaping compliance.

Guide

Is THCA Legal in North Carolina? 2025 NC Hemp Rules & Retailer Compliance Guide

THCA is legal in North Carolina under Chapter 18D as of October 1, 2025, with retailer registration, total-THC testing, and a 1mg delta-9 serving cap.

Analysis

Measurable THC: Decoding State and Federal Limits in Proposed Legislation 2025

Proposed 2025 state and federal legislation redefines measurable THC, tightening compliance thresholds for hemp producers, distributors, and US retailers.

News

Connecticut’s New THC Thresholds: Impact on Local Hemp Farmers

Connecticut's hemp rules effective October 1, 2025 cap manufactured hemp products at 1 milligram THC per serving, among the strictest state thresholds.

News

California's Emergency Ban on Hemp Products with Detectable THC: What It Means for the Industry

California's emergency ban on hemp products with detectable THC reshapes the state's CBD and hemp sector with new compliance obligations and enforcement risks.

Analysis

Federal Push for Stricter Hemp Oversight: What Producers Need to Know

USDA and DEA stepped up federal hemp oversight in 2024, targeting unregulated cannabinoids like delta-8 THC and tightening compliance for producers.

Analysis

Congressional Crackdown? Proposed Stricter Hemp Limits Explained

Congressional 2024-2025 proposals to tighten federal hemp limits would reshape the hemp-derived cannabinoid industry built on the 2018 Farm Bill's 0.3% line.

Guide

Hemp Regulation 2025: What’s Changing in Federal and State Rules for Delta‑8, THCa, and Hemp‑Derived THC

In 2025, states are restricting delta-8, delta-10, and THCa while the 2018 Farm Bill hemp definition holds federally and DEA keeps synthetic THCs as Schedule I.

Guide

From Biomass to Bottle: 15 AI Prompts Every Hemp-Derived THC Manufacturer Needs

Fifteen AI prompts help hemp-derived THC manufacturers tackle Farm Bill delta-9 limits, ISO-17025 testing, cGMP, FSMA, and interstate shipping rules.

Template / SOP

SOP Guide for Cannabis Cultivation & Processing: Ensure Compliance with These 15 Prompts

Fifteen AI prompts help cannabis cultivation and processing operators draft compliant SOPs for lab testing, packaging, and distribution under state regulations.